A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: X4P-001
Sponsor: Abbisko Therapeutics Co, Ltd